Nifty
:
25966.40
Sensex
:
84929.36
150.85 (0.58%)
447.55 (0.53%)
Nifty
Sensex
:
:
25966.40
84929.36
150.85 (0.58%)
447.55 (0.53%)

Infinium Pharmachem Ltd.

Chemicals

Rating :
48/99

BSE: Not Listed | NSE: INFINIUM

NSE BSE
221.10
19-Dec-2025
  • Open
  • High
  • Low
  • Previous Close
  •  225.1
  •  225.1
  •  221.1
  •  224.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1000
  •  223100
  •  337
  •  213.9

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 344.54
  • 43.03
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 361.45
  • N/A
  • 3.20

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 59.91%
  • 0.18%
  • 37.21%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.70%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Net Sales
-
155.71
135.64
114.22
99.12
Net Sales Growth
-
14.80%
18.75%
15.23%
 
Cost Of Goods Sold
-
117.60
103.10
80.57
76.74
Gross Profit
-
38.11
32.54
33.65
22.38
GP Margin
-
24.47%
23.99%
29.46%
22.58%
Total Expenditure
-
139.23
117.11
98.18
89.09
Power & Fuel Cost
-
1.31
1.12
0.63
0.77
% Of Sales
-
0.84%
0.83%
0.55%
0.78%
Employee Cost
-
7.43
4.08
3.72
2.10
% Of Sales
-
4.77%
3.01%
3.26%
2.12%
Manufacturing Exp.
-
3.46
2.90
2.12
1.92
% Of Sales
-
2.22%
2.14%
1.86%
1.94%
General & Admin Exp.
-
2.81
3.08
3.64
3.04
% Of Sales
-
1.80%
2.27%
3.19%
3.07%
Selling & Distn. Exp.
-
2.72
2.54
7.12
4.30
% Of Sales
-
1.75%
1.87%
6.23%
4.34%
Miscellaneous Exp.
-
3.90
0.29
0.37
0.22
% Of Sales
-
2.50%
0.21%
0.32%
0.22%
EBITDA
-
16.48
18.53
16.04
10.03
EBITDA Margin
-
10.58%
13.66%
14.04%
10.12%
Other Income
-
2.12
1.54
1.35
0.93
Interest
-
3.73
2.19
3.10
1.70
Depreciation
-
3.29
2.67
1.34
0.63
PBT
-
11.57
15.21
12.95
8.63
Tax
-
3.73
3.71
3.14
1.95
Tax Rate
-
32.24%
24.39%
24.25%
22.60%
PAT
-
8.14
11.30
9.49
6.11
PAT before Minority Interest
-
7.84
11.50
9.82
6.69
Minority Interest
-
0.30
-0.20
-0.33
-0.58
PAT Margin
-
5.23%
8.33%
8.31%
6.16%
PAT Growth
-
-27.96%
19.07%
55.32%
 
EPS
-
5.22
7.24
6.08
3.92

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Shareholder's Funds
109.46
58.78
22.56
13.10
Share Capital
15.58
13.92
5.08
1.02
Total Reserves
93.88
44.86
17.48
12.09
Non-Current Liabilities
9.85
7.79
10.01
13.56
Secured Loans
4.42
7.25
9.55
10.61
Unsecured Loans
5.57
0.56
0.51
3.01
Long Term Provisions
0.00
0.00
0.00
0.00
Current Liabilities
63.59
17.41
36.77
31.45
Trade Payables
12.39
4.51
6.83
11.82
Other Current Liabilities
10.98
4.87
6.83
8.24
Short Term Borrowings
34.85
3.44
19.18
8.67
Short Term Provisions
5.37
4.59
3.94
2.73
Total Liabilities
198.23
85.43
70.56
58.93
Net Block
24.16
19.64
18.81
4.20
Gross Block
35.44
27.63
24.19
8.24
Accumulated Depreciation
11.28
7.99
5.38
4.04
Non Current Assets
58.32
20.42
19.25
15.25
Capital Work in Progress
0.85
0.02
0.00
8.48
Non Current Investment
29.02
0.00
0.00
0.00
Long Term Loans & Adv.
4.29
0.77
0.44
2.57
Other Non Current Assets
0.00
0.00
0.00
0.00
Current Assets
139.92
65.01
51.31
43.68
Current Investments
0.00
0.00
0.00
0.00
Inventories
44.25
24.69
19.72
16.36
Sundry Debtors
33.75
20.45
15.43
15.39
Cash & Bank
34.84
11.91
5.98
5.45
Other Current Assets
27.07
0.00
0.00
0.00
Short Term Loans & Adv.
26.62
7.95
10.18
6.48
Net Current Assets
76.33
47.60
14.54
12.23
Total Assets
198.24
85.43
70.56
58.93

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
-29.12
-13.04
8.59
11.80
PBT
11.57
15.21
12.95
8.63
Adjustment
7.38
4.80
4.10
1.76
Changes in Working Capital
-44.21
-29.38
-5.35
3.36
Cash after chg. in Working capital
-25.26
-9.37
11.71
13.75
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-3.86
-3.67
-3.12
-1.96
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-27.24
-3.79
-4.96
-6.63
Net Fixed Assets
-4.41
-3.26
-4.65
Net Investments
-15.32
0.00
-0.08
Others
-7.51
-0.53
-0.23
Cash from Financing Activity
79.29
22.77
-3.10
-1.70
Net Cash Inflow / Outflow
22.93
5.93
0.53
3.46
Opening Cash & Equivalents
11.91
5.98
5.45
1.99
Closing Cash & Equivalent
34.84
11.91
5.98
5.45

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
70.25
42.24
22.19
12.89
ROA
5.53%
14.75%
15.16%
14.37%
ROE
9.32%
28.28%
55.06%
66.44%
ROCE
13.23%
28.57%
36.74%
38.88%
Fixed Asset Turnover
4.94
5.24
7.05
12.11
Receivable days
63.52
48.28
49.25
49.49
Inventory Days
80.81
59.76
57.64
47.40
Payable days
0.00
0.00
0.00
28.25
Cash Conversion Cycle
144.34
108.04
106.89
68.64
Total Debt/Equity
0.47
0.19
1.30
1.72
Interest Cover
4.10
7.94
5.17
6.07

Annual Reports:

FY 2025
FY 2024
FY 2023

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.